{
    "Trade/Device Name(s)": [
        "Liquichek Cardiac Markers Plus Control LT"
    ],
    "Submitter Information": "Bio-Rad Laboratories",
    "510(k) Number": "K150300",
    "Predicate Device Reference 510(k) Number(s)": [
        "K050537"
    ],
    "Regulatory Class": "Class I, Reserved",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "January 26, 2015",
    "Summary Letter Received Date": "February 6, 2015",
    "Submission Date": "December 10, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "B-type Natriuretic Peptide (BNP)",
        "CK-MB Isoenzyme",
        "C-Reactive Protein (CRP)",
        "Creatine Kinase (CK)",
        "D-dimer",
        "Digitoxin",
        "Homocysteine",
        "Myeloperoxidase (MPO)",
        "Myoglobin",
        "N-terminal pro-Brain Natriuretic Peptide (NT-proBNP)",
        "Troponin I",
        "Troponin T"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Liquichek Cardiac Markers Plus Control LT, an assayed human serum-based quality control for cardiac and toxicology markers.",
    "Indications for Use Summary": "Intended for use as an assayed quality control serum to monitor the precision of laboratory testing procedures for specified cardiac and toxicology analytes.",
    "fda_folder": "Clinical Chemistry"
}